Back to results
CompletedPhase 1

A Phase I Study to Assess the Pharmacokinetics of GSK2798745 Tablets

NCT02925546

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

GSK Investigational Site

Overland Park, Kansas, United States

View on ClinicalTrials.gov
A Phase I Study to Assess the Pharmacokinetics of GSK2798745 Tablets — TrialFind